The Accelerated Cure Project for Multiple Sclerosis launched a new website to better support caregivers of people with MS.

PTD802 is a selective inhibitor of the GPR17 receptor and is made to restore myelin, a process known as remyelination, in ...

Gadoquatrane, a contrast agent Bayer is developing for use in MRI scans, like those done in MS, uses 60% less gadolinium and ...

TG Therapeutics said it is working to develop a subcutaneous (under-the-skin) version of relapsing MS therapy Briumvi.

Columnist Desiree Lama has kept working when her body has called for rest and relaxation. Her new approach is that breaks are ...

Relapsing-remitting multiple sclerosis is an unpredictable disease marked by relapses and remissions, but there are options ...

Apps for people with multiple sclerosis can help track symptoms and medications and support communication and home ...

Multiple sclerosis can impact your mental health, but there are ways to protect and support your emotional wellness.

Switching therapies is a common part of multiple sclerosis management and may be considered for several reasons.

Patient enrollment is completed ahead of schedule for Contineum's Phase 2 clinical trial of PIPE-307, an oral remyelination ...

Setting a specific, attainable New Year's resolution is key to following through, says columnist Leigh Anne Nelson, who ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.